Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
Cancer Incidence in Five Continents
1966 • 5,960 citations
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
2003 • 2,629 citations
Use and misuse of population attributable fractions.
1998 • 1,583 citations
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
2002 • 595 citations
AGA technical review on the evaluation of liver chemistry tests
2002 • 552 citations
Nonalcoholic Fatty Liver Disease
2003 • 444 citations
Obesity and hepatocellular carcinoma
2004 • 393 citations
NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
2002 • 389 citations
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
1998 • 312 citations
Hepatocellular carcinoma: Recent trends in Japan
2004 • 302 citations
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
1998 • 254 citations
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
2004 • 247 citations
Baseline Survey of JPHC Study Design and Participation Rate
2001 • 245 citations
Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection in Japan: Projection to Other Countries in the Foreseeable Future
2002 • 233 citations
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
2000 • 224 citations
Influence of Coffee Drinking on Subsequent Risk of Hepatocellular Carcinoma: A Prospective Study in Japan
2005 • 218 citations
Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
2005 • 202 citations
Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study
2002 • 202 citations
Prospective study on anti-hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
2001 • 169 citations
Treatment of patients with hepatitis C and normal serum aminotransferase levels
2002 • 147 citations
A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase
2005 • 82 citations
Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus
2002 • 81 citations
A Relationship between the Evolution of Hepatitis C Virus Variants, Liver Damage, and Hepatocellular Carcinoma in Patients with Hepatitis C Viremia
2000 • 75 citations
Background Characteristics of Basic Health Examination Participants: the JPHC Study Baseline Survey
2003 • 57 citations
Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus‐positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus
2004 • 56 citations
Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus‐associated cirrhosis
2002 • 49 citations
Alanine aminotransferase level as a predictor of hepatitis C virus‐associated hepatocellular carcinoma incidence in a community‐based population in Japan
2006 • 38 citations
Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients
2004 • 30 citations
Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study
2002 • 25 citations